PEB Stock Analysis: Pebblebrook Hotel Trust | NYSE
REIT - Hotel & Motel | NYSE, USA | Market Cap: 2.155m USD | 12M Return: 87.3% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 47.1M
Qual. Beats: 2
Rev. Trend: -64.6%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Pebblebrook Hotel Trust (PEB) is a publicly traded real estate investment trust (REIT) and the largest owner of urban and resort lifestyle hotels in the United States. REITs typically operate under a structure that requires distributing the majority of taxable income to shareholders, with revenue generated primarily through property ownership and, in some cases, direct operations.
The Companys portfolio consists of 43 hotels totaling approximately 10,900 guest rooms across 13 urban and resort markets. As a hotel and resort REIT, Pebblebrooks business model focuses on lodging assets in high-demand lifestyle destinations, with income derived from room revenue and ancillary hotel services such as food and beverage operations.
Pebblebrook is headquartered in Bethesda, Maryland, where it was incorporated in October 2009, with its IPO completed later that year on December 9, 2009. The trust is classified within the Real Estate sector under the Hotel & Resort REITs sub-industry.
- Urban RevPAR pressured by soft corporate and group demand
- Resort market acquisitions lift portfolio pricing and margins
- Fed rate cuts reduce hotel REIT debt refinancing costs
| Net Income: -52.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.57 > 1.0 |
| NWC/Revenue: -31.71% < 20% (prev -7.66%; Δ -24.05% < -1%) |
| CFO/TA 0.05 > 3% & CFO 283.4m > Net Income -52.1m |
| Net Debt (2.55b) to EBITDA (282.4m): 9.03 < 3 |
| Current Ratio: 0.34 > 1.5 & < 3 |
| Outstanding Shares: last quarter (113.3m) vs 12m ago -4.93% < -2% |
| Gross Margin: 17.85% > 18% (prev 24.69%; Δ -6.84% > 0.5%) |
| Asset Turnover: 27.40% > 50% (prev 25.83%; Δ 1.57% > 0%) |
| Interest Coverage Ratio: 0.62 > 6 (EBIT TTM 60.3m / Interest Expense TTM 97.4m) |
| A: -0.09 (Total Current Assets 244.3m - Total Current Liabilities 720.3m) / Total Assets 5.30b |
| B: -0.29 (Retained Earnings -1.53b / Total Assets 5.30b) |
| C: 0.01 (EBIT TTM 60.3m / Avg Total Assets 5.48b) |
| D: 0.88 (Book Value of Equity 2.44b / Total Liabilities 2.77b) |
| Altman-Z'' = -0.53 = B |
| DSRI: 0.89 (Receivables 39.7m/43.2m, Revenue 1.50b/1.46b) |
| GMI: 1.38 (GM 24.69% / 17.85%) |
| AQI: 0.28 (AQ_t 0.01 / AQ_t-1 0.02) |
| SGI: 1.03 (Revenue 1.50b / 1.46b) |
| TATA: -0.06 (NI -52.1m - CFO 283.4m) / TA 5.30b) |
| Beneish M = -3.18 (Cap -4..+1) = AA |
As of July 21, 2026, the stock is trading at USD 19.31 with a total of 1,852,872 shares traded. Over the past week, the price has changed by +5.40%, over one month by +3.21%, over three months by +36.54% and over the past year by +87.32%.
Current recommended Stop Loss: 18.60 (which is 3.7% or 1.3 ATR below the current price).
Pebblebrook Hotel Trust has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold PEB.
- StrongBuy: 2
- Buy: 1
- Hold: 8
- Sell: 1
- StrongSell: 2
| Analysts Target Price | 16.9 | -12.4% |
P/E Forward = 24.57
P/S = 1.4359
P/B = 0.8844
P/EG = 3.2069
Revenue TTM = 1.50b USD
EBIT TTM = 60.3m USD
EBITDA TTM = 282.4m USD
Long Term Debt = 1.72b USD (from longTermDebt, last quarter)
Short Term Debt = 360.0m USD (from shortTermDebt, last quarter)
Debt = 2.75b USD (from shortLongTermDebtTotal, last quarter) + Leases 333.0m
Net Debt = 2.55b USD (calculated: Debt 2.75b - CCE 196.2m)
Enterprise Value = 4.70b USD (2.16b + Debt 2.75b - CCE 196.2m)
Interest Coverage Ratio = 0.62 (Ebit TTM 60.3m / Interest Expense TTM 97.4m)
EV/FCF = 18.32x (Enterprise Value 4.70b / FCF TTM 256.8m)
FCF Yield = 5.46% (FCF TTM 256.8m / Enterprise Value 4.70b)
FCF Margin = 17.11% (FCF TTM 256.8m / Revenue TTM 1.50b)
Net Margin = -3.47% (Net Income TTM -52.1m / Revenue TTM 1.50b)
Gross Margin = 17.85% ((Revenue TTM 1.50b - Cost of Revenue TTM 1.23b) / Revenue TTM)
Gross Margin QoQ = 23.37% (prev -10.59%)
Tobins Q-Ratio = 0.89 (Enterprise Value 4.70b / Total Assets 5.30b)
Interest Expense / Debt = 3.55% (Interest Expense 97.4m / Debt 2.75b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 47.6m (EBIT 60.3m * (1 - 21.00%))
Current Ratio = 0.34 (Total Current Assets 244.3m / Total Current Liabilities 720.3m)
Debt / Equity = 1.13 (Debt 2.75b / totalStockholderEquity, last quarter 2.44b)
Debt / EBITDA = 9.03 (Net Debt 2.55b / EBITDA 282.4m)
Debt / FCF = 9.93 (Net Debt 2.55b / FCF TTM 256.8m)
Total Stockholder Equity = 2.51b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.95% (Net Income -52.1m / Total Assets 5.30b)
RoE = -2.07% (Net Income TTM -52.1m / Total Stockholder Equity 2.51b)
RoCE = 1.42% (EBIT 60.3m / Capital Employed (Equity 2.51b + L.T.Debt 1.72b))
RoIC = 0.98% (NOPAT 47.6m / Invested Capital 4.87b)
WACC = 6.14% (E(2.16b)/V(4.90b) * Re(10.40%) + D(2.75b)/V(4.90b) * Rd(3.55%) * (1-Tc(0.21)))
Discount Rate = 10.40% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -48.35 | Cagr: -3.16%
[DCF] Terminal Value 73.10% ; FCFF base≈298.9m ; Y1≈262.1m ; Y5≈211.8m
[DCF] Fair Price = 7.50 (EV 3.40b - Net Debt 2.55b = Equity 849.9m / Shares 113.4m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.23 | # QB: 2
Revenue Correlation: -64.56 | Revenue CAGR: -80.31% | SUE: 4.0 | # QB: 2
EPS current Quarter (2026-06-30): EPS=0.10 | Chg30d=+0.00% | Revisions=+0% | Analysts=2
EPS next Quarter (2026-09-30): EPS=0.01 | Chg30d=N/A | Revisions=+0% | Analysts=2
EPS current Year (2026-12-31): EPS=-0.32 | Chg30d=+42.86% | Revisions=+0% | GrowthEPS=+28.0% | GrowthRev=-0.0%
EPS next Year (2027-12-31): EPS=-0.31 | Chg30d=+14.02% | Revisions=-25% | GrowthEPS=+4.2% | GrowthRev=+1.7%
[Analyst] Revisions Ratio: -25% (up=0, down=1)